ubs glp-1 sales forecast Receptor Agonist Market Size GLP-1 Receptor Agonist Market Size,

SS-31 (Elamipretide, D-Arg-dimethylTyr-Lys-Phe-NH2) is a mitochondria-targeted

Preclinical studies demonstrate their capacity to reduce retinal ganglion cell apoptosis in diabetic models (Figure 1, this review comprehensively analyzes the mechanistic basis of GLP-1RAs in ocular diseases, synthesizes emerging clinical and preclinical evidence, and underscores their potential to redefine therapeutic strategies for vision-threatening disorders through multi-targeted disease modification

Drugs such as semaglutide, liraglutide, and exenatide already play a major role in glucose control and cardiovascular risk reduction

AC Immune